Correlation Between NewAmsterdam Pharma and Precigen
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Precigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Precigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Precigen, you can compare the effects of market volatilities on NewAmsterdam Pharma and Precigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Precigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Precigen.
Diversification Opportunities for NewAmsterdam Pharma and Precigen
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NewAmsterdam and Precigen is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Precigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precigen and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Precigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precigen has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Precigen go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Precigen
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Precigen. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 1.38 times less risky than Precigen. The stock trades about -0.15 of its potential returns per unit of risk. The Precigen is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 130.00 in Precigen on November 28, 2024 and sell it today you would earn a total of 51.00 from holding Precigen or generate 39.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Precigen
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Precigen |
NewAmsterdam Pharma and Precigen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Precigen
The main advantage of trading using opposite NewAmsterdam Pharma and Precigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Precigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will offset losses from the drop in Precigen's long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Precigen vs. CorMedix | Precigen vs. Sangamo Therapeutics | Precigen vs. Aptose Biosciences | Precigen vs. Corvus Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |